ライフサイエンスコーパス: urinary

1 This report demonstrates that urinary 2-MPC can be considered an A. lumbricoides-speci

2 there was a significant association between urinary 2-MPC levels and both worm counts (p = 0.023) an

3 outputs were melatonin amplitude (overnight urinary 6-sulfatoxymelatonin (aMT6s)) and timing (dim li

4 Urinary 6-sulphatoxymelatonin is not a reliable measure

5 reduction in fecundability among males with urinary acetaminophen concentrations in the highest quar

6 ck ascending limb (mTAL) plays a key role in urinary acid and NaCl excretion.

7 ly hyperuricemia with UA crystalluria due to urinary acidification caused tubular obstruction, inflam

8 Baseline and incident urinary ACR >=30 mg/g were not associated with probable

9 d with probable dementia or MCI, nor did the urinary ACR modify the effect of intensive treatment on

10 emphasizes the difficulties in interpreting urinary albumin levels in early disease models.

11 cal Evaluation) trial in patients with T2DM, urinary albumin-creatinine ratio >300 mg/g, and estimate

12 HbA1c levels, urinary albumin-creatinine ratio (p = 0.041), average ce

13 sortium provided GWAS summary data for eGFR, urinary albumin-creatinine ratio (UACR), BUN, and serum

14 Urinary albumin-to-creatinine ratio (ACR) is a marker of

15 imated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR), with cancer i

16 Eligible patients had a urinary albumin-to-creatinine ratio (with albumin measur

17 rea, and diabetic retinopathy, or they had a urinary albumin-to-creatinine ratio of 300 to 5000 and a

18 lobin A1c levels, creatinine levels, and the urinary albumin-to-creatinine ratio were recorded.

19 e protein, sST2, galectin-3, cystatin-C, and urinary albumin-to-creatinine ratio.

20 aseline and longitudinal changes in eGFR and urinary albumin-to-creatinine ratio.

21 GFR 20-44 or 45-59 ml/min per 1.73 m(2) with urinary albumin/creatinine (ACR) >=50 mg/g and serum bic

22 e, known diabetes duration, waist/hip ratio, urinary albumin/creatinine ratio (ACR) and fasting C-pep

23 ney disease and no history of gout who had a urinary albumin:creatinine ratio of 265 or higher (with

24 Urinary aldosterone was measured in participants in high

25 Mean adjusted levels of urinary aldosterone were 6.5 mug/24 h (95% CI, 5.2 to 7.

26 ivo application of secretin induced a marked urinary alkalization, an effect absent in mice lacking p

27 The higher dose lowered urinary ammonium excretion and increased serum bicarbona

28 Mean urinary ammonium excretion was 25% lower and serum bicar

29 s with T2D and DR had smaller PIPR and lower urinary aMT6s than other groups (p < 0.001).

30 hagia, optic atrophy, dysarthria, as well as urinary and bowel incontinence.

31 The ratio between urinary and fecal excretion was also altered in antibiot

32 Urinary and plasma d3- and d6-alpha-CEHC concentrations

33 t were guideline-concordant in uncomplicated urinary and upper and lower respiratory tract infections

34 , whereas diuretics did significantly reduce urinary angiotensinogen and beta2-microglobulin excretio

35 1; 95% confidence interval [CI], 1.18-1.23), urinary antibiotic use (RR, 1.33; 95% CI, 1.28-1.38), an

36 Speciated urinary arsenic (As) (inorganic + monomethyl + dimethyl

37 ction, 5 CpGs remained associated with total urinary As (pBonferroni < 0.05), located in SLC7A11, ANK

38 , methylation at 20 CpGs was associated with urinary As after false discovery rate (FDR) correction (

39 e investigated the association between total urinary As and locus-specific DNA methylation in the Str

40 ults with low-to-moderate As exposure [total urinary As, mean (+/-SD) mug/g creatinine: 11.7 (10.6)].

41 We have successfully validated our urinary biomarker panel, which was improved by substitut

42 The performance of the urinary biomarker, tissue inhibitor of metalloproteinase

43 Emerging urinary biomarkers continue to show promise in evaluatin

44 ostic potential of radiological findings and urinary biomarkers derived from the urothelium of patien

45 cytokine in mouse interstitial fluid and of urinary biomarkers in patient samples.

46 (MURs) that are able to specifically detect urinary biomarkers including gamma-glutamyl transferase

47 xamined whether trimester-specific blood and urinary biomarkers of DBP were associated with small for

48 e examined longitudinal associations between urinary biomarkers of oxidant stress, 8-OH deoxyguanosin

49 f archival renal biopsies and discovered two urinary biomarkers that may be used for specific clinica

50 hthalates and compared them to corresponding urinary biomarkers.

51 ter correlation coefficients with respective urinary biomarkers.

52 tions between concentrations or detection of urinary bisphenols and morbidity outcomes and assessed h

53 uracy to within approximately 20% of in vivo urinary bladder radiotracer concentrations.

54 e users analyzed SPECT/CT images for in vivo urinary bladder radiotracer uptake using quantitative so

55 1.4 muSv/MBq for an adult male, with a 1.5-h urinary bladder voiding interval.

56 ans with the highest absorbed doses were the urinary bladder wall (0.38 mSv/MBq) and kidneys (0.054 m

57 ysiologic accumulation of radiotracer in the urinary bladder which may cause some lesions in its vici

58 nal gland resembles a kidney, connected to a urinary bladder with a nephropore (exit opening) and a c

59 1.3 cm) and a fistula between the appendix, urinary bladder, right scrotum, and right groin.

60 prognosis than urothelial carcinomas of the urinary bladder.

61 ft ventricle; liver; spleen; kidneys; bowel; urinary bladder; gluteus muscle; and malignant lesions.

62 We estimated differences in patient-reported urinary, bowel, sexual, and hormonal function-Expanded P

63 We hypothesized that posttreatment urinary BPA (uBPA) concentrations would be higher among

64 SGS lack DAF and stain positive for C3d, and urinary C3a positively correlates with the degree of pro

65 usted odds ratio, 0.13; 95% CI, 0.1-0.2) and urinary catheter (adjusted odds ratio, 0.28; 95% CI, 0.1

66 I/1000-catheter days by 63% (5.9 to 2.2) and urinary catheter days/patient by 37% (1.1 to 0.69, all P

67 ment, early ambulation, and early removal of urinary catheter) was implemented in five academic and c

68 n a third cohort, we observed an increase in urinary CCL7 levels in AKI, supporting the clinical impo

69 Urinary CD163 <370 ng/mmol at 6 months predicted complet

70 Urinary CD163 <370 ng/mmol or >370 ng/mmol perfectly agr

71 In addition, we evaluated urinary CD163 agreement with histologic activity in 19 p

72 Evaluation of urinary CD163 in patients with persistent proteinuria at

73 Urinary CD163 levels were significantly higher in patien

74 Urinary CD163 reflects histologic inflammation in lupus

75 We also examined relationships between urinary compounds and blood pressure (BP).

76 ormed genome-wide association studies of the urinary concentrations of 1,172 metabolites among 1,627

77 We measured maternal urinary concentrations of 18 phthalate metabolites and 8

78 ere fit to estimate the associations between urinary concentrations of 6 chemical exposure measures (

79 For example, urinary concentrations of benzoic acid were higher in ca

80 Maternal urinary concentrations of bisphenols were not associated

81 Urinary concentrations of BPA, PA, and phthalate metabol

82 We quantified urinary concentrations of eight phthalate metabolites us

83 lite groups) and clinical renal outcomes and urinary concentrations of KIM-1, NGAL, 8-OHdG, and F2-is

84 Higher urinary concentrations of phthalate metabolites during e

85 mice exhibited reduced plasma and increased urinary concentrations of the cationic amino acids.

86 Tissue and urinary (corrected for creatinine) arsenic content was h

87 Here, we examine age-related changes in urinary cortisol in a 20-y longitudinal study of wild ch

88 odality for this purpose [GFR measurement by urinary Creatinine Clearance (uCrCl) versus GFR estimati

89 ed standard and kinetic equations as well as urinary creatinine clearance.

90 locker use, BMI z-score for age and sex, and urinary creatinine.

91 We also show that that urinary CTXII had the strongest and consistent associati

92 Accordingly, urinary CTXII may aid in early diagnosis of OA in sympto

93 s only 4 (serum Coll2-1 NO2, CS846, COMP and urinary CTXII) were consistently associated with establi

94 Cumulative urinary d3-alpha-CEHC excretion was not significantly ch

95 Mean +/- SEM cumulative urinary d6-alpha-CEHC derived from the intravenous dose

96 Urinary damage markers and IL6 levels were similarly red

97 Other blood and urinary DBP biomarkers examined were unrelated to SGA, L

98 Mixtures of urinary DEHP metabolites were inversely associated with

99 7.4 billion [95% CI, $75.0-$100.1 billion]), urinary diseases ($86.0 billion [95% CI, $76.3-$95.9 bil

100 p and two (1%) cases of reversible renal and urinary disorders (one case of each) occurred in the 197

101 gressive therapy with radical cystectomy and urinary diversion or trimodal therapy with maximal endos

102 n cystogene proteins are detectable in human urinary ELVs and that all three undergo post-translation

103 whereas GFR, plasma renin concentration, and urinary endothelin-1 excretion were similar between knoc

104 ers the advantages of (18)F labeling and low urinary excretion compared with (68)Ga-PSMA-11.

105 h' efficiency uptake kinetics and fractional urinary excretion of 0.025%, whereas albumin and alpha(1

106 ptake kinetics and 50-fold higher fractional urinary excretion of 1.15%.

107 Urinary excretion of all other analytes was unchanged be

108 glomeruli compared with normal controls, and urinary excretion of both cathepsins was significantly g

109 Herein we report urinary excretion of the latter analytes and related fra

110 d that reduced PT length can account for the urinary excretion profile in LS.

111 mall molecules with fast blood clearance and urinary excretion.

112 umulation of [(11)C]13 and hepatobiliary and urinary excretions.

113 PKD1, PKD2 and PKHD1 genes, are abundant in urinary exosome-like vesicles (ELVs) where they form the

114 evel of glycan microheterogeneity within the urinary exosomes, finding on average 5.9 glycans per sit

115 ction, 39 cm(3) +/- 39 (39% +/- 29); maximum urinary flow rate, 6 mL/sec +/- 10 (155% +/- 293); and p

116 Score (IPSS), quality-of-life score, maximum urinary flow rate, postvoid residual volume, prostate-sp

117 nges were demonstrated (p <.05) in PSA, peak urinary flow, QoL (quality of life) questionnaire and th

118 Urinary function was assessed by residual urine volume,

119 identifies PIEZO2 as a key mechanosensor in urinary function.

120 , an affected individual had mildly elevated urinary galactitol, which has been linked to cataract de

121 actose challenge whereas values obtained for urinary galactose/creatinine were lower than the existin

122 Plasma glucose and urinary galactose/creatinine were unreliable (AUC < 0.70

123 Integrated analysis of urinary gene expression and metabolite signatures unveil

124 empagliflozin promotes osmotic diuresis via urinary glucose excretion and therefore, might offer a n

125 in reduced postprandial PG through increased urinary glucose excretion.

126 Metabolic adaptations to induced urinary glucose loss include reduced fat mass and more k

127 e sodium-glucose cotransport) further limits urinary glucose loss.

128 ite-specific changes in regard to the common urinary glycoprotein, uromodulin.

129 t first step in understanding the functional urinary glycoproteome.

130 uminuria, mesangial matrix accumulation, and urinary H(2)O(2) Administration of MTP-131 significantly

131 ficantly inhibited increases in albuminuria, urinary H(2)O(2), and mesangial matrix accumulation in d

132 association between longitudinally measured urinary hCG and early miscarriage.

133 fibrosis (CF) do not respond with increased urinary HCO(3) (-) excretion after stimulation with secr

134 lts define the mechanism of secretin-induced urinary HCO(3) (-) excretion, explain metabolic alkalosi

135 F mice showed a greatly attenuated or absent urinary HCO(3) (-)-excreting ability.

136 Conventional methods for urinary HP analysis based on liquid chromatography with

137 MSI-CE-MS/MS as compared to total hydrolyzed urinary HP by GC-MS due to the low residual levels of fr

138 racy with a mean recovery of (93 +/- 3%) for urinary HP-G at three concentration levels with adequate

139 ias (mean bias = 15%, n = 55) when measuring urinary HP-G by MSI-CE-MS/MS as compared to total hydrol

140 dinally measured in all participants include urinary hydroxy-polycyclic aromatic hydrocarbons, volati

141 [33%-41%] to 15% [12%-20%], p < 0.001), and urinary incontinence (43% [39%-47%) to 29% [24%-35%], p

142 ), reoperation (4.1% vs. 3.0%, p = 0.758) or urinary incontinence (5.0% vs. 0%, p = 0.195).

143 (1) identify risk factors related to stress urinary incontinence (SUI) and postnatal depression (PD)

144 Stress urinary incontinence (SUI) is a common and bothersome co

145 Urinary incontinence (UI) is common among women and cont

146 mplications such as erectile dysfunction and urinary incontinence persist at high incidence rates.

147 Self-reported urinary incontinence was worse at 1 year for those in th

148 ructive pulmonary disease (COPD), asthma, or urinary incontinence.

149 es, and emergence of bacterial resistance in urinary, intestinal, and nasal microbiota.

150 erate iodine deficiency as a baseline median urinary iodine concentration (UIC) of 50-149 ug/L.

151 sCRP) measurement, and proteomic markers and urinary isoprostanes for oxidative measures, together wi

152 after hypoglycemia (91.7 ng/mL) was seen for urinary isoprostanes.

153 Acute tubular necrosis, apoptosis, urinary kidney damage markers, neutrophil gelatinase-ass

154 metabolites were positively associated with urinary KIM-1, NGAL, 8-OHdG, and F2-isoprostane levels o

155 In this study we evaluate urinary LAM in HIV negative, pediatric and adult, pulmon

156 ifferences were found for the sleep/fatigue, urinary (large effects) and miscellaneous NMSS domains (

157 Urinary levels of both T-AN and H-AN negatively correlat

158 io to undergo screening (Xpert MTB/RIF test, urinary lipoarabinomannan test, and chest radiography) t

159 ivariate model analysis showed that the only urinary markers significantly related to eGFR slope were

160 using actigraphy (motion-based) and morning urinary melatonin metabolite.

161 h as knee loading and step aerobics, altered urinary metabolism and downregulated WISP1.

162 rhythms (profiles of serum melatonin and its urinary metabolite 6-sulphatoxymelatonin).

163 Differences in urinary metabolite levels in cases and controls at each

164 Urinary metabolite profiles revealed decreases in acetam

165 n the general US population by measuring its urinary metabolite, N-acetyl-S-(4-hydroxy-2-methyl-2-but

166 significantly associated with corresponding urinary metabolites (r(s) = 0.2-0.6, p < 0.05).

167 d late pregnancy differences in non-targeted urinary metabolites among FGR cases and non-FGR controls

168 16S ribosomal RNA gene sequencing and fecal/urinary metabolites by 1H-NMR spectroscopy was complemen

169 he assay robustly detects and quantifies 142 urinary metabolites including 28 amino acids and derivat

170 r results in one of the largest non-targeted urinary metabolomics study to date demonstrate the role

171 Urinary microbes, especially in aging populations, are a

172 We analysed urinary microbial ATP as a biomarker of urinary tract in

173 large-scale study exploring factors defining urinary microbiome composition in community-dwelling old

174 The urinary microbiome is a relatively unexplored niche that

175 The urinary microbiome is distinct from nearby sites and unr

176 Several elevated urinary molecules are also expressed within the kidneys

177 r proteinuria (e.g. immunoglobulin G [IgG]), urinary nephrin excretion (podocyte injury) and serum le

178 suPAR correlated significantly with urinary nephrin, IgG and albumin levels, suggesting suPA

179 We aimed to determine whether urinary neutrophil gelatinase-associated lipocalin (uNGA

180 is demonstrated strongly increased serum and urinary NGAL levels.

181 kd1 knockout mice were associated with lower urinary nitrite/nitrate excretion and markedly increased

182 diabetes mellitus; 'K', the presence of high urinary or blood ketoacids; and 'A', a high anion gap me

183 no statistically significant differences in urinary or bowel function and quality of life.

184 he highest in RS patients with high level of urinary oxalate, which was positively correlated with ge

185 unattainable sensitivity for characterizing urinary pathogen-derived peptides.

186 predominance of Enterobacteriaceae (54%) as urinary pathogens in heart, lung, and kidney transplant

187 inine ratio: UPPod:CR) and a tubular marker (Urinary pellet aquaporin 2:creatinine ratio) were measur

188 in:nephrin mRNA ratio), podocyte detachment (Urinary pellet podocin mRNA:creatinine ratio: UPPod:CR)

189 Podocyte stress (Urinary pellet podocin:nephrin mRNA ratio), podocyte det

190 Urinary pellet podocyte and tubular mRNA markers were in

191 ite/nitrate excretion and markedly increased urinary PGE(2) excretion, whereas GFR, plasma renin conc

192 ture podocytes) has a profound effect on the urinary phenotype due to its critical roles in both the

193 Inadequate urinary phosphate excretion can lead to severe hyperphos

194 Persistently increased urinary phosphate excretion maintains serum phosphate le

195 ate, parathyroid hormone, FGF23, and 24-hour urinary phosphate.

196 intervention and dust control on children's urinary phthalate metabolite concentrations.

197 otho-hypomorphic mouse (kl/kl) with impaired urinary Pi excretion, low autophagy, and premature organ

198 at new branches and longer paths form on the urinary pole side.

199 yed decreased glomerular filtration rate and urinary potassium excretion associated with hyperkaliemi

200 ed biomarker of platelet COX-1 activity, and urinary prostacyclin metabolite (PGIM) excretion were me

201 glomerular filtration and tubular uptake to urinary protein excretion, we developed a mathematical m

202 T) using Michaelis-Menten kinetics and molar urinary protein measurements taken from human Dent1 dise

203 reased proteinuria over time, as measured by urinary protein:creatinine ratio.

204 In urinary proteins, knee loading in mice and step aerobics

205 eptide on the surface that is cleaved into a urinary reporter upon exposure to specific proteases ove

206 rts the development of activatable molecular urinary reporters (MURs) that are able to specifically d

207 in men with lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruct

208 h bothersome lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruct

209 potentially preventable conditions, such as urinary retention, infection, and pain.

210 s of attraction, ultrasonic vocalization and urinary scent marking, and also serves as a reinforcer i

211 onal studies have found associations between urinary sodium (UNa) with obesity, body shape and compos

212 Study meals reduced 24-hour urinary sodium by 137+/-21 mmol (1500-mg arm) and 82+/-1

213 Because both diets reduced urinary sodium without adverse safety or quality of life

214 rage compliance with meals was 52% (based on urinary sodium) and was not significantly different betw

215 m that can be associated with alterations in urinary solute composition including hypercalciuria.

216 icipants provided >=1 24-h urine sample, and urinary solute excretion was analyzed.

217 , i.e., kidney infection (pyelonephritis) or urinary-source bacteremia, from non-invasive UPEC, defin

218 e that increased deaths were attributable to urinary-source BSI.

219 various conditions, such as kidney disorder, urinary stone disease, urinary tract infection, and cyst

220 TURP and ThuVARP were equivalent for urinary symptom improvement (IPSS) 12-months post-surger

221 rsing home residents is complex, as specific urinary symptoms are often absent and asymptomatic bacte

222 tients were followed up by questionnaires on urinary symptoms, sexual function and impact on quality

223 also observed for symptoms/disorders of the urinary system (OR 1.36, 95% CI 1.19-1.56), asthma (OR 1

224 ures it was 93.1%, and for cultures from the urinary system it was 99.2%.

225 nt organs of the respiratory, digestive, and urinary systems and the CNS.

226 Elimination was via the hepatobiliary and urinary systems.

227 Urinary TCF21 concentration in human showed a positive c

228 Changes in urinary [TIMP-2]*[IGFBP7] following initial fluid resusc

229 easured within 12 hours after admission, and urinary tissue inhibitor of metalloproteinase-2 and insu

230 Urinary tissue inhibitor of metalloproteinase-2 x insuli

231 Urinary tissue inhibitor of metalloproteinase-2 x insuli

232 Congenital anomalies of the kidney and urinary tract (CAKUTs) represent the leading cause of ch

233 The lower urinary tract (LUT) and micturition reflexes are sexuall

234 Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer stage-for-st

235 l roles for the urothelium in the developing urinary tract and in the genesis of CAKUTs.

236 ng) to the quantification of the severity of urinary tract and periprosthetic joint infections.

237 Endometriosis of the bowel and urinary tract are types of extragenital endometriosis th

238 owed a significant association with lung and urinary tract cancers.

239 e biomarkers and their performance in common urinary tract cancers.

240 mportant in health and ailments of the lower urinary tract cause high pathological burden.

241 Patients were excluded if they had upper urinary tract disease, urothelial carcinoma within the p

242 was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomye

243 hat most commonly define catheter-associated urinary tract infection (CAUTI) and encourage further ex

244 en and frequent cause of catheter-associated urinary tract infection (CAUTI).

245 pyrexia (three [4%]), diarrhoea (two [3%]), urinary tract infection (two [3%]), and acute kidney inj

246 spitalized patients treated for pneumonia or urinary tract infection (UTI) and determine whether over

247 A significant proportion of urinary tract infection (UTI) patients experience recurr

248 National guidelines for pneumonia (PNA), urinary tract infection (UTI), and acute bacterial skin

249 r respiratory tract infection (RTI), skin or urinary tract infection (UTI), and antibiotic prescripti

250 ys, including surgical site infection (SSI), urinary tract infection (UTI), and lower respiratory tra

251 ysed urinary microbial ATP as a biomarker of urinary tract infection (UTI), confirming the capability

252 Urinary tract infection (UTIs) was higher in CC group (4

253 li (ExPEC) is the leading cause in humans of urinary tract infection and bacteremia.

254 diabetes, and graft function, posttransplant urinary tract infection and rejection treatment were imp

255 Urinary tract infection and rejection treatment were not

256 ted intraabdominal infection, or complicated urinary tract infection caused by imipenem-nonsusceptibl

257 Antibiotic prescribing for a presumed urinary tract infection is often preceded by inappropria

258 ent) and precipitating factors (for example, urinary tract infection) for delirium have been describe

259 h as kidney disorder, urinary stone disease, urinary tract infection, and cystic fibrosis.

260 Escherichia coli is the leading cause of urinary tract infection, one of the most common bacteria

261 hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyel

262 c obstructive pulmonary disease, arrhythmia, urinary tract infection, septicemia, and stroke from 200

263 regulating an inflammatory response during a urinary tract infection.

264 n mouse models of peritonitis, pneumonia and urinary tract infection.

265 high rate of bacteriuria without documented urinary tract infection.

266 ia, in the absence of signs or symptoms of a urinary tract infection.

267 personnel and number of catheter-associated urinary tract infections (CAUTI) and central line-associ

268 ulting in false positive catheter-associated urinary tract infections (CAUTI).

269 Recurrent urinary tract infections (R-UTIs) are the main cause of

270 sociates with an increased risk of recurrent urinary tract infections (rUTIs) linked to uropathogenic

271 Diagnosing urinary tract infections (UTI) in nursing home residents

272 uropathogenic E. coli - the primary cause of urinary tract infections (UTIs) - can adhere to vaginal

273 Urinary tract infections (UTIs) are common, recurrent in

274 Urinary tract infections (UTIs) represent a major burden

275 he acute pyelonephritis that can result from urinary tract infections (UTIs), which commonly ascend f

276 range of diseases, including respiratory and urinary tract infections and bacteremia.

277 e diseases like sepsis, acute kidney injury, urinary tract infections, and HIV/AIDS.

278 a range of infections, including pneumonias, urinary tract infections, and septicemia, in otherwise h

279 t that contains bacterial species related to urinary tract infections.

280 nd capsule-deficient mutants associated with urinary tract infections.

281 ce, including Escherichia-Shigella linked to urinary tract infections.

282 olvement of the urothelium in patterning the urinary tract is supported by evidence that CAKUTs can a

283 Moreover, the presence of urinary tract malformation was associated with the need

284 symptomatic bacteriuria commonly result from urinary tract malformations or bladder disturbances.

285 AP) and performed a comprehensive screen for urinary tract microbiota signatures, metabolite, and cyt

286 rating endometriosis involving the bowel and urinary tract on abdominal ultrasonography and shows the

287 Enterococcus spp (20%) occurred as urinary tract pathogens in kidney transplant recipients

288 tigate TURP versus ThuVARP in men with lower urinary tract symptoms or urinary retention secondary to

289 in seven UK hospitals with bothersome lower urinary tract symptoms or urinary retention secondary to

290 -menopausal bleeding, rectal bleeding, lower urinary tract symptoms, haematuria, change in bowel habi

291 plasia with good long-term results for lower urinary tract symptoms.

292 mechanosensitive ion channel PIEZO2 in lower urinary tract tissues, where it is required for low-thre

293 li are detected inside vaginal cells and the urinary tract, indicating that vaginal colonization can

294 nd/or congenital anomalies of the kidney and urinary tract.

295 Urinary TXM was reduced by 35% in both experimental arms

296 3) relating rs-fMRI measures to self-report (urinary urge) and physiologic measures (voided volume).

297 lated to the stimulus (volume) and response (urinary urge).

298 symptom complex characterised by symptoms of urinary urgency, increased frequency, nocturia, with or

299 Detection of urinary volatile organic compounds and ELISA assays show

300 The primary outcome was change in 24-hour urinary volume from baseline to week 6.